From Molecule to Patient: A Biotech Perspective
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021
|
| Online Access: | https://hdl.handle.net/1721.1/136560 |
| _version_ | 1826206204145172480 |
|---|---|
| author | Langer, Robert Jaklenec, Ana Traverso, Giovanni Hartman, Daniel |
| author_facet | Langer, Robert Jaklenec, Ana Traverso, Giovanni Hartman, Daniel |
| author_sort | Langer, Robert |
| collection | MIT |
| first_indexed | 2024-09-23T13:25:26Z |
| format | Article |
| id | mit-1721.1/136560 |
| institution | Massachusetts Institute of Technology |
| language | English |
| last_indexed | 2024-09-23T13:25:26Z |
| publishDate | 2021 |
| publisher | Wiley |
| record_format | dspace |
| spelling | mit-1721.1/1365602021-10-28T03:52:13Z From Molecule to Patient: A Biotech Perspective Langer, Robert Jaklenec, Ana Traverso, Giovanni Hartman, Daniel 2021-10-27T20:35:58Z 2021-10-27T20:35:58Z 2020 2021-06-22T14:12:14Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/136560 en 10.1002/CPT.1676 Clinical Pharmacology and Therapeutics Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/ application/pdf Wiley Wiley |
| spellingShingle | Langer, Robert Jaklenec, Ana Traverso, Giovanni Hartman, Daniel From Molecule to Patient: A Biotech Perspective |
| title | From Molecule to Patient: A Biotech Perspective |
| title_full | From Molecule to Patient: A Biotech Perspective |
| title_fullStr | From Molecule to Patient: A Biotech Perspective |
| title_full_unstemmed | From Molecule to Patient: A Biotech Perspective |
| title_short | From Molecule to Patient: A Biotech Perspective |
| title_sort | from molecule to patient a biotech perspective |
| url | https://hdl.handle.net/1721.1/136560 |
| work_keys_str_mv | AT langerrobert frommoleculetopatientabiotechperspective AT jaklenecana frommoleculetopatientabiotechperspective AT traversogiovanni frommoleculetopatientabiotechperspective AT hartmandaniel frommoleculetopatientabiotechperspective |